9/28/2023CDE Solicits Comments on the Technical Guidelines for Clinical Efficac...

9/28/2023CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...

9/28/2023Chime Biologics Enters Strategic Deal with Kings Pharm to Accelerate B...

9/27/2023CDE Issues the Technical Guidelines for Non-clinical Research of Antib...

9/26/2023WuXi Debuts First Vaccine CDMO Site in China

9/26/2023Chinese Patents of Four MNC Originator Drugs Face Imminent Invalidatio...

9/26/2023Control Dispute with Hengrui Led to Dissolution Drama of Reistone Biop...

9/26/2023SAMR Imposed Fines and Confiscations Totaling Over CNY 300 Million in...

9/26/2023CDE Solicits Comments on the Technical Guidelines for the Assessment o...

9/26/2023China Becomes Country with Highest and Increasingly Younger Alzheimer ...

9/26/2023China's Shifting Cost Dynamic to Help It Develop Own Biologics Niche: ...

9/25/2023CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...

9/25/2023AbbVie Terminates Deal with I-Mab to Exit Race for CD47 Space

9/25/2023CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...

9/25/2023CDE Solicits Comments on the Acceptance and Review Guide to GQCE Studi...

9/24/2023Six Central Government Agencies Issue A New Batch of Rare Disease Cata...

9/24/2023PackGene and Kudo Partner to Offer Customized mRNA Manufacturing Servi...

9/24/2023Chime Biologics Enter Global Strategic Deal with Panolos for Multi-spe...

9/21/2023Recent Executive Moves

9/21/2023Drug R&D and Product Registration News Digest 09/2023 (3)

9/21/2023Meitheal Licenses U.S. Rights of Insulin Biosimilars from Tonghua Dong...

9/20/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (74...

9/20/2023CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...

9/20/2023CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...

9/20/2023A Share-Listed Chinese MedPharm Cos Report Broadly Positive Performanc...

9/20/2023IQVIA: Chinese Hospital Drug Market Rebounded in MAT Q2/2023

9/20/2023Everest Medicines Enters into Collaboration and License Agreement with...

9/20/2023NHSA Clears Two Additional Drugs from Form Evaluation for 2023 NRDL In...

9/19/2023Novartis, BeiGene Agree to Terminate Deal for Cancer Drug Candidate

9/19/2023CDE Solicits Comments on the Dossier Requirements for Communication an...

Page:27/33 Total number of articles:961: [First][<<] [25] [26] [27] [28] [29] [>>] [End]